Inotek Pharma Raises $18 Million
Inotek Pharmaceuticals Corp., a Beverly, Mass.-based drug development company, has raised $18 million in fourth-round funding. Devon Park Bioventures led the round, and was joined by return backers Rho Ventures, Care Capital, Pitango Venture Capital, MedImmune Ventures and Bio*One Capital. The company previously raised around $75 million.
11 June 2010•4 mins read
